• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含药物的胶体液滴大小和无定形溶解度对药物膜通透性的影响:综合分析

Impact of colloidal drug-rich droplet size and amorphous solubility on drug membrane permeability: A comprehensive analysis.

作者信息

Ueda Keisuke, Takemoto Shiryu, Higashi Kenjirou, Moribe Kunikazu

机构信息

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

出版信息

J Pharm Sci. 2025 Jan;114(1):136-144. doi: 10.1016/j.xphs.2024.06.017. Epub 2024 Jun 26.

DOI:10.1016/j.xphs.2024.06.017
PMID:38942292
Abstract

This study aimed to investigate the impact of amorphous solubility and colloidal drug-rich droplets on drug absorption. The amorphous solubility of cilnidipine (CND) in AS-HF grade of hypromellose acetate succinate (HPMC-AS) solution was significantly reduced compared to that in non-polymer solution due to AS-HF partitioning into the CND-rich phase. In contrast, AS-LF grade of HPMC-AS has minimal effect on the amorphous solubility. The size of colloidal CND-rich droplets formed in the CND-supersaturated solution was less than 100 nm in the presence of AS-HF, while 200-450 nm in the presence of AS-LF. When the CND concentrations were near the amorphous solubility, CND membrane flux was reduced in the presence of AS-HF due to the decrease in the amorphous solubility of CND. However, the CND flux increased with the increase in CND-rich droplets, especially in the AS-HF solution. The size reduction of the CND-rich droplets led to their effective diffusion into the unstirred water layer, enhancing CND flux. In higher CND concentration regions, the CND flux became higher in the AS-HF solution than in the AS-LF solution. Thus, it is essential to elucidate the drug concentration-dependent impact of the colloidal drug-rich droplets on the drug absorption performance to optimize supersaturating formulations.

摘要

本研究旨在探讨无定形溶解度和富含胶体药物的液滴对药物吸收的影响。由于醋酸羟丙甲纤维素琥珀酸酯(HPMC-AS)的AS-HF级分分配到富含西尼地平(CND)的相中,与非聚合物溶液相比,CND在AS-HF级分的HPMC-AS溶液中的无定形溶解度显著降低。相比之下,HPMC-AS的AS-LF级分对无定形溶解度的影响最小。在存在AS-HF的情况下,在CND过饱和溶液中形成的富含胶体CND的液滴尺寸小于100nm,而在存在AS-LF的情况下为200-450nm。当CND浓度接近无定形溶解度时,由于CND无定形溶解度的降低,在存在AS-HF的情况下CND膜通量降低。然而,CND通量随着富含CND的液滴的增加而增加,尤其是在AS-HF溶液中。富含CND的液滴尺寸减小导致它们有效地扩散到未搅拌的水层中,从而提高了CND通量。在较高的CND浓度区域,AS-HF溶液中的CND通量高于AS-LF溶液中的CND通量。因此,阐明富含胶体药物的液滴对药物吸收性能的药物浓度依赖性影响对于优化过饱和制剂至关重要。

相似文献

1
Impact of colloidal drug-rich droplet size and amorphous solubility on drug membrane permeability: A comprehensive analysis.富含药物的胶体液滴大小和无定形溶解度对药物膜通透性的影响:综合分析
J Pharm Sci. 2025 Jan;114(1):136-144. doi: 10.1016/j.xphs.2024.06.017. Epub 2024 Jun 26.
2
Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.聚合物类型对无定形溶解度和富含药物相胶体稳定性的影响:使用核磁共振波谱法进行的机制研究。
Mol Pharm. 2020 Apr 6;17(4):1352-1362. doi: 10.1021/acs.molpharmaceut.0c00061. Epub 2020 Mar 5.
3
Impact of Hypromellose Acetate Succinate Grade on Drug Amorphous Solubility and In Vitro Membrane Transport.醋酸羟丙甲纤维素琥珀酸酯等级对药物无定形溶解度和体外膜转运的影响。
J Pharm Sci. 2020 Aug;109(8):2464-2473. doi: 10.1016/j.xphs.2020.04.014. Epub 2020 Apr 28.
4
Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.表面活性剂在富含药物的纳米液滴中的分配及其对药物热力学活性和液滴大小的影响。
J Control Release. 2021 Feb 10;330:229-243. doi: 10.1016/j.jconrel.2020.12.018. Epub 2020 Dec 16.
5
Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.超饱和达那唑溶液的特性——聚合物对溶液性质和相变的影响
Pharm Res. 2016 May;33(5):1276-88. doi: 10.1007/s11095-016-1871-y. Epub 2016 Feb 18.
6
Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.月桂醇硫酸酯钠与羟丙基甲基纤维素醋酸琥珀酸酯发生竞争性相互作用,从而降低泊沙康唑/羟丙基甲基纤维素醋酸琥珀酸酯无定形固体分散体的口服生物利用度。
Mol Pharm. 2016 Aug 1;13(8):2787-95. doi: 10.1021/acs.molpharmaceut.6b00391. Epub 2016 Jul 1.
7
Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.用羟丙甲纤维素衍生物稳定的高过饱和硝苯地平溶液相分离行为的直接核磁共振监测
Mol Pharm. 2017 Jul 3;14(7):2314-2322. doi: 10.1021/acs.molpharmaceut.7b00178. Epub 2017 Jun 6.
8
Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid-Liquid Phase Separation.通过液-液相分离生成富含药物的纳米液滴对肠道药物吸收增强的定量研究。
Mol Pharm. 2024 Apr 1;21(4):1745-1755. doi: 10.1021/acs.molpharmaceut.3c01078. Epub 2024 Mar 19.
9
Variable-Temperature NMR Analysis of the Thermodynamics of Polymer Partitioning between Aqueous and Drug-Rich Phases and Its Significance for Amorphous Formulations.变温核磁分析聚合物在水相和药物富相之间分配热力学及其对无定形制剂的意义。
Mol Pharm. 2022 Jan 3;19(1):100-114. doi: 10.1021/acs.molpharmaceut.1c00664. Epub 2021 Oct 26.
10
Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.伊曲康唑与羟丙甲纤维素醋酸琥珀酸酯的富药胶体对大鼠体外膜通量及口服生物利用度的影响
Mol Pharm. 2017 Jul 3;14(7):2437-2449. doi: 10.1021/acs.molpharmaceut.7b00338. Epub 2017 Jun 22.

引用本文的文献

1
Mechanistic Insights into Amorphous Solid Dispersions: Bridging Theory and Practice in Drug Delivery.非晶态固体分散体的作用机制见解:药物递送中理论与实践的桥梁
Pharm Res. 2025 Jan;42(1):1-23. doi: 10.1007/s11095-024-03808-w. Epub 2025 Jan 23.
2
Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of -(((1,4)-4-((6-fluorobenzo[]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist.用于改善作为神经肽Y5受体拮抗剂的-(((1,4)-4-((6-氟苯并恶唑-2-基)氨基)环己基)甲基)-2-甲基丙烷-2-磺酰胺溶出曲线的共无定形固体分散体系统。
Pharmaceutics. 2024 Oct 2;16(10):1293. doi: 10.3390/pharmaceutics16101293.